Trium Capital LLP AZN Holdings History

Number of Shares
102,641.00
Current Holdings Value*
$7.54 Mil
% of Portfolio
0.95%
Total Estimate Gain
$-296,632.49
% of Total Estimate Gain
-4.00%

Trium Capital LLP's AstraZeneca PLC Holding Summary

As of 2025-03-31, Trium Capital LLP held 102,641.00 shares of AstraZeneca PLC(AZN), totaling $7.54 Mil. This investment constitutes 0.95% of their stock portfolio, and Trium Capital LLP now holds 0% of the outstanding AstraZeneca PLC(AZN) stock.

The initial trade took place in 2025Q1. And since then Trium Capital LLP has made 1 purchases of AZN, at an average price of $72.34, for a total of 102,641.00 shares. Based on historical transaction data and AZN's current price of $69.45, Trium Capital LLP's estimated gain on his AZN holdings is $-296,632.49, reflecting a -4.00% gain to date.

Trium Capital LLP AZN ($69.45) Holding Chart

Trium Capital LLP AZN ($69.45) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1